Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01181648 · ClinicalTrials.gov registry record
Long-Term Impact of Human Papillomavirus (HPV) on Quality of Life
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 210
- Enrollment target
NCT01181648: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT01181648 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 210 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01181648 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 210 participants
- Enrollment target
Study Summary
The investigators are doing this study to learn about the quality of life patients have at the end of treatment. Some patients' cancers are related to human papilloma virus or HPV; others are not. HPV is a virus that can be sexually transmitted and is known to cause some types of cancers. If your throat cancer was related to HPV, your doctor can discuss this with you in detail. The investigators want to see if there are differences in quality of life between patients whose cancers are caused by HPV and those who cancers are not caused by HPV. Throat cancers caused by HPV behave differently than throat cancers not caused by HPV. The investigators believe that patients with these two different types of throat cancer will also have different experiences after completing therapy. The investigators would like to understand what those differences are. The long-term goal of this study is to see what symptoms most patients have. The investigators can then try to treat them earlier, and hopefully, improve the symptoms. The investigators will also be able to plan more research to improve treatment for symptoms following treatment for cancer of the mouth and throat.
Interventions
- BEHAVIORAL questionnaire and semi-structured interviews
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2010-08 |
| Est. Completion | 2018-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01181648
The ClinicalTrials.gov registry entry for NCT01181648 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 210 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which questionnaire and semi-structured interviews is the first listed.
NCT01181648 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01181648 about?
NCT01181648 is a clinical study titled "Long-Term Impact of Human Papillomavirus (HPV) on Quality of Life". The investigators are doing this study to learn about the quality of life patients have at the end of treatment. Some patients' cancers are related to human papilloma virus or HPV; others are not. HPV is a virus that can be sexually transmitted and is known to cause some types of cancers. If your th...
What is the current status of trial NCT01181648?
This trial is currently completed. The enrollment target is 210 participants. The study started on 2010-08. Estimated completion is 2018-06.
What interventions are being tested in trial NCT01181648?
The interventions under investigation include: questionnaire and semi-structured interviews (BEHAVIORAL).
Who is sponsoring clinical trial NCT01181648?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.